Biotechnology company developing AI-enhanced bacteriophage (phage) therapies to combat bacterial diseases, initially focused on animal health with the longer-term goal of expanding to human health. The platform combines microbiology and AI to design tailored, adaptable phage treatments; the company has filed a patent for its AI technology and received authorisation to market personalised phage-based veterinary medicines.